|
2006 Journal Article A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-productsZimanyi, M. A., Denton, K. M., Forbes, J. M., Thallas-Bonke, V., Thomas, M. C., Poon, F. and Black, M. J. (2006). A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products. Diabetologia, 49 (4), 801-810. doi: 10.1007/s00125-006-0175-x |
|
2006 Journal Article Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823))Forbes, J. M., Yee, L. T.L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., Cooper, M. E. and Allen, T. J. (2006). Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823)). Diabetes, 55 (3) |
|
2006 Journal Article Novel therapeutics for diabetic micro- and macrovascular complicationsSoro-Paavonen, A. and Forbes, J. M. (2006). Novel therapeutics for diabetic micro- and macrovascular complications. Current Medicinal Chemistry, 13 (15), 1777-1788. doi: 10.2174/092986706777452515 |
|
2005 Conference Publication Advanced glycation end products and diabetic nephropathyThomas, Merlin C., Forbes, Josephine M. and Cooper, Mark E. (2005). Advanced glycation end products and diabetic nephropathy. doi: 10.1097/01.mjt.0000178769.52610.69 |
|
2005 Journal Article Interactions between renin angiotensin system and advanced glycation in the kidneyThomas, Merlin C., Tikellis, Christos, Burns, Wendy M., Bialkowski, Katarzyna, Cao, Zemin, Coughlan, Melinda T., Jandeleit-Dahm, Karen, Cooper, Mark E. and Forbes, Josephine M. (2005). Interactions between renin angiotensin system and advanced glycation in the kidney. Journal of the American Society of Nephrology, 16 (10), 2976-2984. doi: 10.1681/ASN.2005010013 |
|
2005 Journal Article Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsCalkin, Anna C., Forbes, Josephine M., Smith, Craig M., Lassila, Markus, Cooper, Mark E., Jandeleit-Dahm, Karin A. and Allen, Terri J. (2005). Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 (9), 1903-1909. doi: 10.1161/01.ATV.0000177813.99577.6b |
|
2005 Journal Article Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathyForbes, Josephine M., Thorpe, Suzanne R., Thallas-Bonke, Vicki, Pete, Josefa, Thomas, Merlin C., Deemer, Elizabeth R., Bassal, Sahar, El-Osta, Assam, Long, David M., Panagiotopoulos, Sianna, Jerums, George, Osicka, Tanya M. and Cooper, Mark E. (2005). Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. Journal of the American Society of Nephrology, 16 (8), 2363-2372. doi: 10.1681/ASN.2005010062 |
|
2005 Journal Article High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionKooptiwut, Suwattanee, Kebede, Melkam, Zraika, Sakeneh, Visinoni, Sherley, Aston-Mourney, Kathryn, Favaloro, Jenny, Tikellis, Chris, Thomas, Merlin C., Forbes, Josephine M., Cooper, Mark E., Dunlop, Marjorie, Proietto, Joseph and Andrikopoulos, Sofianos (2005). High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. Journal of Molecular Endocrinology, 35 (1), 39-48. doi: 10.1677/jme.1.01720 |
|
2005 Journal Article Agents in development for the treatment of diabetic nephropathyFukami, Kei, Cooper, Mark and Forbes, Josephine M. (2005). Agents in development for the treatment of diabetic nephropathy. Expert Opinion On Investigational Drugs, 14 (3), 279-294. doi: 10.1517/13543784.14.3.279 |
|
2005 Conference Publication Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?Forbes, JM, Coughlan, MT, Fukami, K, Laskowski, A, Thallas-Bonke, V, Dinh, D, Long, DM, Brownlee, M, Cooper, ME and Thorburn, DR (2005). Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER. |
|
2005 Conference Publication Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?Thomas, Merlin C., Forbes, Josephine M., MacIsaac, Richard, Jerums, George and Cooper, Mark E. (2005). Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?. New York Academy of Sciences. doi: 10.1196/annals.1333.073 |
|
2005 Conference Publication Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?Coughlan, Melinda T., Cooper, Mark E. and Forbes, Josephine M. (2005). Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?. New York Academy of Sciences. doi: 10.1196/annals.1333.087 |
|
2005 Conference Publication Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonistsCooper, ME, Forbes, JM, Smith, CM, Lassila, M, Jandeleit-Dahm, KA, Allen, TJ and Calkin, AC (2005). Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER. |
|
2005 Conference Publication Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetesCoughlan, MT, Thorburn, DR, Fukami, K, Laskowski, A, Thallas-Bonke, V, Long, DM, Brownlee, M, Cooper, ME and Forbes, JM (2005). Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER. |
|
2005 Journal Article Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin systemRizkalla, Bishoy, Forbes, Josephine M., Cao, Zemin, Boner, Geoffrey and Cooper, Mark E. (2005). Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. Journal of Hypertension, 23 (1), 153-164. doi: 10.1097/00004872-200501000-00026 |
|
2005 Journal Article Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathyThomas, M. C., Forbes, J. M. and Cooper, M. E. (2005). Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy. Annals of the New York Academy of Sciences, 1043 (1), 927-927. doi: 10.1196/annals.1333.141 |
|
2004 Journal Article Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathwayThallas-Bonke, Vicki, Lindschau, Carsten, Rizkalla, Bishoy, Bach, Leon A., Boner, Geoffrey, Meier, Matthias, Haller, Hermann, Cooper, Mark E. and Forbes, Josephine M. (2004). Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathway. Diabetes, 53 (11), 2921-2930. doi: 10.2337/diabetes.53.11.2921 |
|
2004 Journal Article The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetesForbes, Josephine M., Thomas, Merlin C., Thorpe, Suzanne R., Alderson, Nathan L. and Cooper, Mark E. (2004). The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes. Kidney International, Supplement, 66 (S92), S105-S107. doi: 10.1111/j.1523-1755.2004.09225.x |
|
2004 Journal Article The role of advanced glycation in reduced organic cation transport associated with experimental diabetesThomas, Merlin C., Tikellis, Christos, Kantharidis, Phillip, Burns, Wendy C., Cooper, Mark E. and Forbes, Josephine M. (2004). The role of advanced glycation in reduced organic cation transport associated with experimental diabetes. Journal of Pharmacology and Experimental Therapeutics, 311 (2), 456-466. doi: 10.1124/jpet.104.070672 |
|
2004 Conference Publication Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouseJandeleit-Dahm, KAM, Lassila, M, Seah, KK, Allen, TJ, Thallas, V, Thomas, MC, Candido, R, Burns, WC, Forbes, JM, Calkin, AC and Cooper, ME (2004). Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse. 40th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Munich Germany, Sep 05-09, 2004. SPRINGER. |
